Nakayama-Kitamura Kimiko, Shigemoto-Mogami Yukari, Piantino Marie, Naka Yasuhiro, Yamada Asuka, Kitano Shiro, Furihata Tomomi, Matsusaki Michiya, Sato Kaoru
Laboratory of Neuropharmacology, Division of Pharmacology, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki City 210-9501, Kanagawa, Japan.
Joint Research Laboratory for Social Implementation of Cultured Meat, Osaka University, 2-1 Yamadaoka, Suita 565-0871, Osaka, Japan.
Biomedicines. 2024 Oct 31;12(11):2500. doi: 10.3390/biomedicines12112500.
The blood-brain barrier (BBB) strictly regulates the penetration of substances into the brain, which, although important for maintaining brain homeostasis, may delay drug development because of the difficulties in predicting pharmacokinetics/pharmacodynamics (PKPD), toxicokinetics/toxicodynamics (TKTD), toxicity, safety, and efficacy in the central nervous system (CNS). Moreover, BBB functional proteins show species differences; therefore, humanized in vitro BBB models are urgently needed to improve the predictability of preclinical studies. Recently, international trends in the 3Rs in animal experiments and the approval of the FDA Modernization Act 2.0 have accelerated the application of microphysiological systems (MPSs) in preclinical studies, and in vitro BBB models have become synonymous with BBB-MPSs. Recently, we developed an industrialized humanized BBB-MPS, BBB-NET. In our previous report, we reproduced transferrin receptor (TfR)-mediated transcytosis with high efficiency and robustness, using hydrogels including fibrin and collagen I microfibers (CMFs).
We investigated how adding CMFs to the fibrin gel benefits BBB-NETs.
We showed that CMFs accelerate capillary network formation and maturation by promoting astrocyte (AC) survival, and clarified that integrin β1 is involved in the mechanism of CMFs.
Our data suggest that the quality control (QC) of CMFs is important for ensuring the stable production of BBB-NETs.
血脑屏障(BBB)严格调控物质进入大脑,这对于维持脑内稳态很重要,但由于预测药代动力学/药效学(PKPD)、毒代动力学/毒效学(TKTD)、毒性、安全性及中枢神经系统(CNS)疗效存在困难,可能会延迟药物研发。此外,BBB功能蛋白存在物种差异;因此,迫切需要人源化体外BBB模型以提高临床前研究的可预测性。近来,动物实验3R原则的国际趋势及美国食品药品监督管理局(FDA)《2.0版现代化法案》的批准加速了微生理系统(MPS)在临床前研究中的应用,体外BBB模型已成为BBB-MPS的代名词。最近,我们开发了一种工业化的人源化BBB-MPS,即BBB-NET。在我们之前的报告中,我们使用包含纤维蛋白和I型胶原微纤维(CMF)的水凝胶高效且稳定地重现了转铁蛋白受体(TfR)介导的转胞吞作用。
我们研究了向纤维蛋白凝胶中添加CMF对BBB-NET的益处。
我们发现CMF通过促进星形胶质细胞(AC)存活加速毛细血管网络的形成和成熟,并阐明整合素β1参与了CMF的作用机制。
我们的数据表明,CMF的质量控制(QC)对于确保BBB-NET的稳定生产很重要。